Dawn Christine Maroney Sells 122,707 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Maroney sold 122,707 shares of Alignment Healthcare stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $12.68, for a total value of $1,555,924.76. Following the sale, the president directly owned 794,606 shares in the company, valued at $10,075,604.08. The trade was a 13.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, June 15th, Dawn Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $19.55, for a total value of $586,500.00.

Alignment Healthcare Price Performance

Alignment Healthcare stock opened at $12.61 on Friday. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70. The company has a market capitalization of $2.62 billion, a PE ratio of 66.37 and a beta of 1.11. Alignment Healthcare, Inc. has a one year low of $12.39 and a one year high of $25.12. The business has a 50 day simple moving average of $16.17 and a 200 day simple moving average of $18.03.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.04. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The firm had revenue of $1.34 billion for the quarter, compared to analysts’ expectations of $1.31 billion. During the same period in the prior year, the business posted $0.07 earnings per share. The business’s revenue was up 31.6% compared to the same quarter last year. On average, sell-side analysts forecast that Alignment Healthcare, Inc. will post 0.17 EPS for the current fiscal year.

Institutional Trading of Alignment Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in ALHC. Wellington Management Group LLP raised its holdings in shares of Alignment Healthcare by 9.8% in the second quarter. Wellington Management Group LLP now owns 18,780,363 shares of the company’s stock valued at $447,160,000 after buying an additional 1,681,427 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in Alignment Healthcare by 0.6% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock worth $249,715,000 after acquiring an additional 79,268 shares during the last quarter. William Blair Investment Management LLC acquired a new stake in Alignment Healthcare in the 2nd quarter valued at about $184,799,000. Invesco Ltd. increased its position in Alignment Healthcare by 38.9% in the 4th quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock valued at $122,501,000 after acquiring an additional 1,735,962 shares in the last quarter. Finally, California State Teachers Retirement System raised its stake in shares of Alignment Healthcare by 2,587.6% in the second quarter. California State Teachers Retirement System now owns 5,326,749 shares of the company’s stock worth $126,830,000 after acquiring an additional 5,128,549 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ALHC has been the subject of a number of recent analyst reports. UBS Group reiterated a “neutral” rating on shares of Alignment Healthcare in a research report on Wednesday, July 8th. Zacks Research lowered shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. Barclays decreased their price objective on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. TD Cowen reaffirmed a “buy” rating on shares of Alignment Healthcare in a report on Monday, August 3rd. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Alignment Healthcare in a research note on Tuesday, August 4th. Seven equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $23.60.

Key Stories Impacting Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: CEO John Kao’s sales were conducted under a pre-arranged Rule 10b5-1 plan and were intended to cover tax-withholding obligations tied to vested equity awards, reducing the likelihood that the transactions reflect a negative view of Alignment Healthcare’s business prospects. SEC Form 4 filing
• Neutral Sentiment: Alignment Health’s annual survey reported worsening challenges for seniors related to aging in place, support gaps and medical debt. The announcement highlights issues relevant to the company’s target market but does not provide a direct change to revenue, enrollment or earnings expectations. Alignment Health senior survey
• Neutral Sentiment: Reported short interest was zero shares, with a zero-day short-interest ratio. Because the figures show no measurable short position, they provide little evidence of either bearish positioning or potential short-covering support.
• Negative Sentiment: CEO John Kao sold a combined 557,870 shares across September 10–11, worth approximately $7.1 million, reducing his reported ownership. President Dawn Maroney also sold 122,707 shares for about $1.6 million. Although the transactions were tied to tax obligations, their size and timing can weigh on sentiment and may be contributing to the stock’s decline. SEC Form 4 filing
• Negative Sentiment: Kaplan Fox announced an investigation into Alignment Healthcare for possible securities-law violations. The announcement does not establish wrongdoing, but it introduces legal and reputational uncertainty that can pressure the stock. Kaplan Fox investigation announcement

About Alignment Healthcare

Alignment Healthcare, Inc is a technology-enabled healthcare company that provides Medicare Advantage health plans and care-management services for older adults. Through its Alignment Health Plan subsidiary, the company offers insurance coverage designed for Medicare-eligible members, including primary and specialty care coordination, prescription drug benefits, preventive services and access to a network of healthcare providers.

The company combines health-plan operations with proprietary technology intended to support personalized care.